Related by context. All words. (Click for frequent words.) 74 familial clustering 72 sociodemographic variables 72 sociodemographic factors 72 psychosocial variables 71 Genetic variants 71 subclinical atherosclerosis 71 Logistic regression 71 GBA mutations 71 APOE e4 71 Multiple logistic regression 70 genetic loci 70 sociodemographic characteristics 70 familial aggregation 70 multivariate logistic regression 70 logistic regression analyzes 70 Multivariate analysis 70 underlying pathophysiology 70 multivariate analyzes 70 genetic polymorphisms 70 covariate 69 nondemented 69 univariate analyzes 69 genotype phenotype 69 CYP#D# genotype 69 CSF biomarkers 69 alexithymia 69 DNA methylation patterns 69 comorbid disorders 69 genomewide 69 euthymic patients 69 prognostic indicators 69 clinicopathological 69 Univariate analysis 68 Univariate 68 endophenotypes 68 APOE4 68 sociodemographics 68 multiple logistic regression 68 pathophysiological mechanisms 68 APOE ε4 68 Logistic regression analysis 68 nongenetic 68 plasma lipid 68 ABCB1 68 multivariable analysis 68 neuropathologic 68 logistic regression model 67 logistic regression models 67 VKORC1 67 unmeasured confounders 67 etiologic 67 Genetic predisposition 67 EGFR mutation status 67 GABRA2 67 #q# deletion 67 impaired insulin secretion 67 tumor histology 67 bivariate 67 logistic regression analysis 67 serum BDNF 67 Socioeconomic status 67 genetic determinants 67 neurocognitive function 67 comorbid depression 67 thiopurine 67 germline mutations 67 phenotypic expression 67 metabolite concentrations 67 TCF#L# gene 66 ApoE gene 66 premorbid 66 HRQL 66 epistasis 66 epigenetic changes 66 allele frequencies 66 psychiatric comorbidity 66 spirometric 66 polygenic 66 Genetic variations 66 Subgroup analyzes 66 differential gene expression 66 shorter telomere length 66 impaired glucose metabolism 66 conditional logistic regression 66 elevated homocysteine 66 bile acid metabolism 66 serum biomarkers 66 Heritability 66 tumor subtype 66 methylation patterns 66 affective psychosis 66 seropositivity 66 convergent validity 66 prostate cancer CaP 66 inflammatory biomarkers 66 genetic variants associated 66 Genetic variation 66 Cognitive impairment 66 genetic polymorphism 66 Multivariate analyzes 66 Haptoglobin 66 2D 4D ratio 66 intact parathyroid hormone 66 elevated fasting glucose 65 biochemical abnormalities 65 proband 65 multivariate regression analysis 65 Neuroticism 65 elevated triglyceride levels 65 obstructive coronary artery 65 serum PTH 65 UGT#A# * 65 autonomic dysfunction 65 T1DM 65 comorbid anxiety 65 #q# deletion syndrome 65 metabolic dysfunction 65 serum lipid 65 multivariate Cox 65 adiponectin levels 65 LRP5 65 serum markers 65 psychiatric comorbidities 65 pharmacodynamic parameters 65 neurosensory 65 hormone receptor status 65 neurobiological basis 65 MMSE score 65 MTHFD1L gene 65 thyrotropin levels 65 APOE e4 gene 65 vascular dysfunction 65 antiphospholipid antibodies 65 pathophysiological 65 Observational studies 65 susceptibility loci 65 clinico pathological 65 bivariate analyzes 65 multiple linear regression 65 C. pneumoniae 65 HER2 expression 65 hereditary predisposition 65 apolipoprotein E gene 65 echocardiographic parameters 65 highly heritable 65 potentially modifiable 65 gene polymorphisms 65 prostate carcinogenesis 65 CYP#D# gene 65 narcolepsy cataplexy 65 affective psychoses 65 syndromic 65 electrophysiologic 65 antioxidant supplementation 65 unmeasured factors 65 diabetic kidney 65 visceral adiposity 64 meta regression 64 de novo mutations 64 abnormal glucose metabolism 64 CYP#C# gene 64 MYH9 gene 64 aetiological 64 serum lipids 64 ovarian hormones 64 microsatellite instability 64 breast cancer subtypes 64 Telomere length 64 metabolic parameters 64 susceptibility locus 64 G6PD deficiency 64 monoclonal gammopathy 64 lipoprotein profiles 64 FGFs 64 PTPN# 64 pleiotropic effects 64 LRRK2 mutations 64 confounding variables 64 explanatory variables 64 gonadal hormones 64 K ras mutations 64 EBV infection 64 TMPRSS2 ERG fusion 64 neurocognitive impairment 64 CNTNAP2 64 Hp2 2 64 HER2 positivity 64 penetrance 64 APOE gene 64 albumin excretion 64 prognostic variables 64 neurocognitive dysfunction 64 multivariable Cox 64 angiographically 64 arterial thickening 64 hippocampal function 64 residual confounding 64 thrombophilia 64 neuropathological 64 chi squared 64 FGFR2 gene 64 TGFBR1 * 6A 64 CP CPPS 64 psychosocial functioning 64 heritable variation 64 genes predisposing 64 BRCA2 carriers 64 genomewide association studies 64 neurocognitive deficits 64 mutated K ras 64 missense mutations 64 biologic pathways 64 KIBRA 64 ABCB1 gene 64 TOMM# 64 familial pancreatic cancer 64 schizophreniform disorder 64 MDRD 64 serum selenium 64 #q#.# deletion syndrome 64 allelic 64 APOE allele 64 chlamydial infection 64 univariate 64 serum lipid levels 64 5 HTTLPR 64 cardio metabolic 64 carotid IMT 64 chronicity 64 subclinical hyperthyroidism 64 Rh factor 64 APOC3 64 serum retinol 64 assortative mating 64 serum parathyroid hormone 64 KRAS mutation 64 neuropsychological deficits 63 observable characteristics 63 modifier genes 63 sociodemographic 63 BMI z 63 pathogenic mechanisms 63 bronchopulmonary dysplasia BPD 63 pathophysiologic 63 CYP#C# [001] 63 intima media thickness 63 NNRTI resistance 63 mechanistic studies 63 neurodevelopmental outcome 63 metabolic disturbances 63 neurodevelopmental outcomes 63 telomere lengths 63 plasma lipoprotein 63 antenatal depression 63 molecular determinants 63 tumor subtypes 63 DQB1 * 63 HIV HCV coinfected 63 cognitive affective 63 genetic locus 63 apolipoprotein E4 63 abnormal lipid 63 genotypic resistance 63 phenotypic variation 63 prognostically 63 Charlson comorbidity index 63 miRNA expression 63 haematologic 63 Tasigna prolongs 63 nonfasting triglyceride levels 63 genotypic 63 androgen deficiency 63 IPAH 63 fetuin 63 mammographic density 63 autistic traits 63 hematological parameters 63 clefting 63 motor neuron degeneration 63 prognostic significance 63 Prognostic factors 63 plasma lipids 63 stratifying patients 63 adiponectin concentrations 63 Cystatin C 63 heritable diseases 63 CC genotype 63 extramedullary 63 fasting insulin 63 lipid profiles 63 nonalcoholic steatohepatitis NASH 63 HLA DRB1 63 Kaplan Meier curve 63 stepwise logistic regression 63 somatic symptoms 63 2 diabetes T2D 63 albumin excretion rate 63 elevated serum ALT 63 HNPCC 63 airway hyperresponsiveness 63 confounder 63 lipoprotein metabolism 63 SLC#A# [002] 63 MYH9 63 KRAS status 63 covariates 63 Subgroup analysis 63 bivariate analysis 63 Multivariable logistic regression 63 diabetes mellitus DM 63 neuropsychological impairments 63 clinicopathologic 63 multivariate regression 63 Bonferroni correction 63 LQTS 63 MGUS 63 undiagnosed celiac disease 63 MDRD equation 63 p# activation 63 cerebral microbleeds 63 HOMA IR 63 multigene 63 Personality traits 63 neuropsychiatric diseases 63 thyrotropin 63 causal pathway 63 thyroid dysfunction 63 cranial irradiation 63 autoimmune thyroid 63 meta analytic 63 genomic alterations 63 comorbidity 63 adrenal function 63 biochemical markers 63 pharmacologic treatments 63 neurocognitive functioning 63 testicular tumors 63 etiological 63 FGF2 63 histone modifications 63 metabolic syndrome MetS 63 COMT genotype 63 histological subtype 63 multivariable analyzes 63 abdominal adiposity 63 PCNSL 63 inherited mutations 63 predisposing factor 62 Excessive daytime sleepiness 62 mammographically 62 gene polymorphism 62 nongenetic factors 62 allostatic load 62 MEF2A 62 carotid plaque 62 subclinical hypothyroidism 62 apoE4 62 periprocedural MI 62 syndromal 62 SMAD4 62 HER2 overexpression 62 unmeasured confounding 62 airway responsiveness 62 cardioembolic stroke 62 logistic regression 62 heritable genetic 62 gallstone disease 62 affective disorders 62 poor metabolizers 62 HRQOL 62 mitochondrial proteins 62 serum estradiol 62 mitochondrial toxicity 62 sCJD 62 Longitudinal studies 62 serum GGT 62 K ras mutation 62 prognostic markers 62 serum leptin 62 DRD2 62 genetic susceptibilities 62 subclinical disease 62 predictive validity 62 Heavy menstrual bleeding 62 CYP#C# genotype 62 generalized estimating 62 thyroid hormone levels 62 multivariable adjusted 62 surrogate markers 62 Singh Manoux 62 presymptomatic 62 STEP BD 62 gestational diabetes mellitus GDM 62 Pearson correlation coefficients 62 laterality 62 abnormal lipids 62 elevated CRP 62 paternally inherited 62 evolvability 62 depressive symptomatology 62 impaired cognition 62 gene APOE 62 Suicidal ideation 62 trans palmitoleate 62 psychobiological 62 colorectal adenoma 62 Sociodemographic 62 hyper IgE syndrome 62 Angiotensin converting enzyme 62 plasma homocysteine 62 maturational 62 metabolomic profiles 62 socioeconomic status SES 62 poststroke depression 62 sporadic ALS 62 murine models 62 SNP rs# [002] 62 orthologous genes 62 SCN1A 62 adjuvant systemic 62 hematopoietic cancers 62 glycosylated hemoglobin HbA1c 62 genomic imprinting 62 MMSE scores 62 biochemical imbalances 62 dysbindin 62 allelic variation 62 silent myocardial ischemia 62 coinfection 62 RRM1 62 BEXXAR Therapeutic Regimen 62 hippocampal volume 62 Apolipoprotein E 62 MetS 62 epigenetic regulation 62 confounders 62 UGT#A# 62 nosology 62 ANCOVA 62 moderately heritable 62 intracellular signal transduction 62 epigenetic modifications 62 internalizing disorders 62 body fatness 62 pathologic fractures 62 Socio demographic 62 neuroanatomical 62 dysbindin gene 62 Epidemiologic studies 62 carotid plaques 62 Treg cell 62 NRF2 gene 62 sirtuin activators 62 KRAS mutation status 62 glycated hemoglobin HbA1c 62 potential confounding variables 62 Non inferiority 62 neurological abnormalities 62 S. maltophilia 62 Clusterin 62 MC1R 62 aminotransferase 62 STAT4 62 BRCA testing 62 Parkinson Disease PD 62 BRCA2 mutation carriers 62 salivary cortisol 62 primary aldosteronism 62 Chronic pancreatitis 62 apolipoprotein E 62 ε4 62 chromosomal rearrangement 62 metabolic abnormality 62 neuroactive 62 abnormal lipid levels 62 SE alleles 62 somatoform disorders 62 hydroxyvitamin D concentrations 62 hydroxy vitamin D 62 Fragile X gene 62 macrovascular disease 62 ApoE4 62 KIF6 gene variant 62 serum IGF 62 heterozygotes 62 ADRB2 62 aetiology 62 HDL cholesterol triglycerides 62 gene loci 62 physiologic mechanisms 62 antidiabetic medications 62 nonalcoholic steatohepatitis 62 DAT1 62 socioeconomic variables 62 underlying molecular mechanisms 62 coronary calcification 62 developmental trajectories 62 Multiple linear regression 62 progesterone receptor PR 62 carotid atherosclerosis 61 NOD mouse 61 Cardiorespiratory fitness 61 intraobserver 61 neuropsychological functioning 61 hsCRP levels 61 gene locus 61 monozygotic twins 61 functional neuroimaging 61 hereditary hemochromatosis 61 microRNA expression 61 FeNO 61 Leydig cell 61 monogenic 61 arterial calcification 61 ALI ARDS 61 chromosomal aberrations 61 prognostic biomarker 61 retrospective cohort 61 Predisposition 61 insulin resistance syndrome 61 causal pathways 61 SNP rs# [001] 61 prothrombotic 61 Comorbidity 61 ontogenetic 61 breast cancer metastasis 61 transient elastography 61 choroidal vasculopathy 61 Multivariate logistic regression 61 PITX2 methylation 61 subclinical 61 somatic mutations 61 Insulin sensitivity 61 plasma pharmacokinetics 61 carbohydrate intolerance 61 genomic biomarkers 61 NPM1 mutation 61 tHcy 61 ADCS CGIC 61 autosomal dominant inheritance 61 testicular germ cell 61 POAG 61 pathogenetic mechanisms 61 deCODE BreastCancer TM 61 aMCI precursor 61 cTnT 61 odds ratios ORs 61 HIV tropism 61 dietary folate 61 familial predisposition 61 radiographic findings 61 extrapyramidal symptoms 61 orofacial clefts 61 KIAA# 61 dyslipidaemia 61 metabolomic profiling 61 mitochondrial metabolism 61 TOP2A 61 pharmacologic intervention 61 gestational diabetes mellitus 61 folate metabolism 61 BRCA mutation 61 atherothrombotic 61 CHEK2 61 univariate analysis 61 VADT 61 Nicotine dependence 61 differentially expressed genes 61 endocrinologic 61 olfactory dysfunction 61 triacylglycerol concentrations 61 liver histology 61 Meta analyzes 61 glycated hemoglobin levels 61 multifactorial disease 61 Main Outcome Measure 61 TP# mutations 61 sonographic diagnosis 61 prognostic factors 61 ATG#L# 61 neurodevelopmental impairment 61 intracranial stenosis 61 IL#R 61 cortical activation 61 comorbid illnesses 61 ApoE4 gene 61 endometrial thickness 61 HLA DQ2 61 T2DM 61 microalbuminuria 61 Kaplan Meier curves 61 serum calcium 61 SSc 61 chromosome #p#.# 61 Linear regression 61 LPA gene 61 etiologic factors 61 KRAS mutations 61 transgenic mouse models 61 Descriptive statistics 61 LVNC 61 androgen depletion 61 beta1 integrin 61 serum urate levels 61 CYP#A# gene 61 inhibin B 61 chromosomal alterations 61 IDH1 mutation 61 MLH1 61 estrogen metabolism 61 PTEN gene 61 postmenopausal estrogen 61 neuropsychological impairment 61 parous women 61 dysglycemia 61 endogenous estrogen 61 alpha1 antitrypsin deficiency 61 IgA deficiency 61 interindividual variability 61 androgen receptor gene 61 Severe Primary IGFD 61 perinatal outcomes 61 Histologic 61 overt hypothyroidism 61 BRCA1 mutations 61 neuroimaging studies 61 STK# gene 61 PON1 61 depressive symptom 61 anti Mullerian hormone 61 bronchopulmonary dysplasia 61 interobserver 61 clinicopathological features 61 prenatal exposures 61 atherogenic 61 intensive statin therapy 61 colorectal carcinogenesis 61 LDL HDL 61 intersexuality 61 estrogen receptor ER 61 homocysteine concentrations 61 glucose abnormalities 61 triglyceride concentrations 61 inherit predisposition 61 BRAF V#E mutation 61 G allele 61 molecular abnormalities 61 paraneoplastic 61 logistic regressions 61 serum vitamin D 61 cardiac channelopathies 61 posttransplant 61 FASPS 61 Premature Ovarian Failure 61 Hypertriglyceridemia 61 TT genotype 61 noncognitive 61 Prostatitis 61 hypochondriasis 61 KIF6 carriers 61 primary ovarian insufficiency 61 PROactive study 61 anthropometric measures 61 genes CYP#C# 61 genetic syndromes 61 serum homocysteine 61 somatization disorder 61 Hashimoto thyroiditis 61 biologic plausibility 61 ADAMTS# 61 elevated IOP 61 adipokines 61 CYP#C# [002] 61 hematological relapse 61 apolipoprotein B 61 CNPs 61 T2D 61 multivariate adjustment 61 correlational 61 dietary carbohydrate 60 diagnosing ADHD 60 modifiable lifestyle 60 carotid artery thickness 60 TPMT 60 Sjögren syndrome 60 Li Fraumeni 60 phenotypic characteristics 60 metaanalysis 60 mtDNA mutations 60 folate deficiency 60 COMT gene 60 hyperprolactinemia 60 clinically insignificant 60 tumorigenicity 60 remnant lipoproteins 60 multi factorial disease 60 enteroviral infection 60 psychiatric morbidity 60 EQ 5D 60 demyelinating 60 CDH1 60 chorioamnionitis 60 MSH2 60 susceptibility gene 60 prolactin levels 60 comorbid conditions 60 glial tumors 60 perfusion abnormalities 60 endocrine dysfunction 60 CHD mortality 60 mitochondrial mutations 60 HFE gene 60 atherogenic dyslipidemia 60 GH deficiency 60 mitochondrial DNA mtDNA 60 biochemical imbalance 60 pathogenetic 60 immunodeficiencies 60 synovial cells 60 insulin sensitizing drug 60 cystatin C 60 carotid bruit 60 Lipodystrophy 60 untreated hypothyroidism 60 imatinib resistance 60 ORMDL3 60 atypical hyperplasia 60 PsA 60 FUS protein 60 AST ALT 60 fluoroquinolone resistance 60 waist circumference WC 60 Randomized trials 60 HIV seroconversion 60 DRD4 60 lipid parameters 60 beta carotene supplementation 60 microdeletions 60 nondepressed 60 epigenetic mechanisms 60 Symptom severity 60 serologic 60 scintigraphic 60 receptor inhibitor 60 circadian clock genes 60 nonhereditary 60 Logistic regression models 60 neuropsychological assessments 60 PIGF 60 lipid abnormalities 60 apolipoproteins 60 CHD7 60 CETP gene 60 nephrogenic 60 late onset hypogonadism 60 rs# [002] 60 intestinal microflora 60 enterotypes 60 autoimmune pancreatitis 60 neuropsychological assessment 60 glucose homeostasis 60 pharmacokinetic interaction 60 PON1 activity 60 gastric carcinoma 60 prefrontal cortical 60 observable traits 60 HOXB# 60 nonischemic 60 lactate dehydrogenase LDH 60 causative mutations 60 aortic stiffness 60 pleiotropy 60 lipid levels 60 monozygotic twin 60 xenobiotic 60 amyloid deposition 60 FDG PET scans 60 HAQ DI 60 SHANK3 60 obesity insulin resistance 60 metaplasia 60 Sarcopenia 60 ConclusionThis 60 HRQoL 60 postoperative pulmonary 60 COL#A# 60 schizotypal traits 60 microbiomes 60 urolithiasis 60 fasting glucose levels 60 causative genes 60 NHANES III 60 comorbid psychiatric 60 Magnesium deficiency 60 Atkins dieters cardiovascular 60 CALHM1 60 HIV serostatus 60 LDL cholesterol concentrations 60 DRD2 gene 60 microvascular dysfunction 60 lupus anticoagulant 60 microdeletion 60 Dr. Bezprozvanny 60 HLA DRB1 * 60 histopathological 60 prion infection 60 multi infarct dementia 60 impair fertility 60 PTEN mutations 60 epigenetic alterations 60 promoter hypermethylation 60 rs# [001] 60 hypericin 60 pre malignant lesions 60 behavioral disinhibition 60 antiphospholipid syndrome 60 ventilation perfusion 60 hypercalciuria 60 histologic subtype 60 dopamine receptor gene 60 nitrotyrosine 60 ADPKD 60 Genotypic 60 Reynolds Risk Score 60 BRCA1 BRCA2 60 Uncontrolled hypertension 60 obstructive coronary 60 FMRP protein 60 atypical neuroleptics 60 HNSCC 60 COX2 60 serotonin 2A 60 STAT3 signaling 60 indels 60 BMPR2 60 heritable traits 60 HbA1C levels 60 APOL1 60 incidentalomas 60 diathesis 60 normotensive 60 psychosocial stressors 60 electroencephalographic 60 baseline HbA1c 60 neuropsychiatric symptoms 60 RE LY trial 60 genetic aberrations 60 thromboembolic disease 60 euthymic 60 protein conformation 60 benign thyroid nodules 60 Rh incompatibility 60 serologic tests 60 Fasting glucose 60 Depressive symptoms 60 immunomodulation 60 Histological 60 chromosomal anomalies 60 DHEAS 60 CVD mortality 60 C. trachomatis 60 Gestational 60 neuritic 60 attain statistical significance 60 gastric carcinomas 60 atherosclerosis regression 60 inherited predisposition 60 SCD1 60 APOE e4 allele 60 GABRA2 gene 60 pharmacogenetic testing 60 TCF#L# 60 Shortened telomeres 60 neovascular 60 glycaemia 60 prospective multicentre 60 osteoporosis osteopenia 60 pCR 60 AAT deficiency 60 posttreatment 60 Alzheimer Disease AD 60 postoperative delirium 60 IKZF1 60 hypercoagulable 60 epigenetic modification 60 renal carcinoma 60 atherothrombotic disease 60 apo B 60 DHEA supplementation 60 invasive lobular 60 HLA DR4 60 JAK mutations 60 apo E 60 HeFH 60 PI3K signaling 60 GPC5 60 multivariable logistic regression 60 glutamate glutamine 60 rs# [004] 60 genetic relatedness 60 neuronal dysfunction 60 intestinal microbiota 60 gene expression patterns 60 cytogenetic abnormalities 60 autopsied brains 60 Cytogenetic 60 MTHFR 60 covariance 60 biopsychosocial 60 hypermethylated 60 NPM1 gene 60 CARDIA study 60 spontaneous regression 60 ABO blood 60 circadian genes 60 vascular cognitive impairment 60 Complications Trial 60 endocannabinoid signaling 60 cardioprotective effects 60 thyroid deficiency 60 leukocyte counts 60 antitumour 60 habitual snoring 60 interobserver reliability 60 PON1 gene 60 Bacterial vaginosis 60 statistically significant correlation 59 microbleeds 59 neuropsychiatric disorder 59 left ventricular diastolic 59 #q#.# [001] 59 β blockers 59 MECP2 gene 59 lowest tertile 59 microscopic colitis 59 BPS IC 59 prefrontal regions 59 dysfunctional voiding 59 gut microbiota 59 varicocele 59 premenopause 59 PARP inhibition 59 hepatic fibrosis 59 florbetaben 59 triglyceride lowering 59 KCNH2 59 Li Fraumeni syndrome 59 Alequel 59 symptomatic VTE 59 lipid lowering medications 59 clade B 59 recurrent miscarriage 59 serum cholesterol 59 neurohormonal 59 Wwox 59 elevated LDH 59 synaptic function 59 BRAF V#E 59 Endothelial dysfunction 59 estimated GFR 59 choroidal neovascularization 59 Orthostatic hypotension 59 lupus scleroderma 59 comorbid psychiatric disorders 59 improves insulin sensitivity 59 developmental neurotoxicity 59 vitamin D inadequacy 59 p# mutations 59 serum phosphate 59 functional polymorphism 59 MC4R gene 59 acetabular dysplasia 59 polycystic ovary syndrome PCOS 59 genomic biomarker 59 dopaminergic therapy 59 Poisson regression 59 ELBW infants 59 CEACAM1 59 ultrastructural 59 V Leiden 59 Comorbidities 59 proton MR spectroscopy 59 ASCUS 59 perilipin 59 ascertainment bias 59 progressive neurodegenerative disorder 59 hormonal abnormalities 59 apoE 59 gastric adenocarcinoma 59 antidepressant efficacy 59 hypertensive retinopathy 59 mutant allele 59 GSTM1 gene 59 glycogen metabolism 59 proliferative retinopathy 59 symptomology 59 hydroxyvitamin D levels 59 ERK signaling 59 carotid stenosis